Nevro Appoints Finance Executive Roderick MacLeod as Chief Financial Officer

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

Nevro Corp. today announced the appointment of Roderick (“Rod”) MacLeod as Chief Financial Officer, effective June 15, 2020, with global responsibility for Finance, IT and Customer Service.  Mr. MacLeod succeeds Andrew Galligan, who is retiring but will remain with the Company during a transition period.

“Rod is a proven leader with a track record of success in finance and operations leadership.  We are pleased that Rod is joining the Nevro executive team at a point in our history where his extensive financial, strategic and industry experience will help us accelerate toward long-term sustainable growth and strong financial performance for our shareholders,” said D. Keith Grossman, Chairman, CEO and President, Nevro.

“I’m very pleased to join Nevro and I view this as an exciting opportunity to continue to build a great company while helping patients who suffer from chronic pain,” said Rod MacLeod.  “I look forward to working closely with Keith and the rest of the Nevro team to execute on the Company’s growth strategy.”

Regarding Andrew Galligan’s retirement Grossman added, “Nevro has benefitted tremendously from Andrew’s leadership over the past decade and he has played a vital role in establishing a solid financial and operational foundation for the Company.  On behalf of the entire organization, I want to thank Andrew for his many accomplishments as CFO.  I also want to thank Andrew personally for being a great resource for me as I came on board, and for remaining with the Company during this transition period.”

“I’d like to thank Keith and the entire Nevro team – it’s truly been an honor to be a part of Nevro for these ten years,” said Andrew Galligan, Chief Financial Officer, Nevro.  “I’m proud of all that we’ve accomplished together and I’m confident that the Company is well positioned for future growth and success.”

Roderick MacLeod joins Nevro with more than 25 years of experience in financial and executive leadership roles in healthcare and technology.  Most recently he served as Vice President of Finance of Stryker Endoscopy, a $1.8 billion division of Stryker Corp that develops and manufactures medical devices used in minimally invasive surgical procedures.  During his 16-year career at Stryker Endoscopy, Mr. MacLeod played a key role in growing the division from $500 million to $1.8 billion in revenue.  Prior to this role, Mr. MacLeod was Controller for Stryker Endoscopy.  Previously, Mr. MacLeod was Vice President of Finance and Administration at Lumenare Networks, a Sunnyvale-based software company.  Earlier in his career, Mr. MacLeod was Financial Manager/Controller at United Airlines and was a Senior Operational and Audit Consultant at Arthur Andersen & Co.  Rod MacLeod graduated from the J.L. Kellogg Graduate School of Management at Northwestern University with a Master of Management degree and received his Bachelor of Arts degree in Economics from Harvard University.



Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.